Services for Measuring Cell-Mediated Immune Responses

ProImmune Ltd announced that its assay services for measuring cell mediated immune responses, including ELISpot assays, are now available in accordance with GLP and GCP.

Assays for measuring cellular immune responses help address key questions in the development of biological therapies. However, pharmaceutical companies often have difficulties integrating these assays into their preclinical and clinical development processes while complying with GLP and GCP. Outsourcing cellular assays to a dedicated facility working to GLP and GCP standards overcomes this problem, ensures data fully meet the requirements of regulatory submission and saves the cost and effort of setting up these timeconsuming assays in-house.

Dr Nikolai Schwabe, CEO of ProImmune, said: “Complying formally with GLP and GCP standards addresses an unmet need for many developers of novel therapies. It also demonstrates ProImmune’s commitment to supporting our customers’ requirement for understanding and characterising immune response in all phases of
pharmaceutical product development.”